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Abstract 
Background: Malaria is a notifiable disease in the Netherlands, a non-endemic country. Imported malaria infections 
occur regularly among travellers, migrants and visitors. Surveillance data were analysed from 2008 to 2015. Trends in 
amounts of notifications among risk groups were analysed using Poisson regression. For asylum seekers, yearly inci-
dence was calculated per region of origin, using national asylum request statistics as denominator data. For tourists, 
denominator data were used from travel statistics to estimate incidence per travel region up to 2012.
Results: A modest increase in overall imported malaria notifications occurred in 2008–2015 (from 222 in 2008 to 344 
in 2015). Notably, in 2014 and 2015 sharp increases were seen in malaria among travellers visiting friends and relatives 
(VFR), and in asylum seekers. Of all Plasmodium falciparum infections, most (1254/1337; 93.8%) were imported from 
Africa; 1037/1337 (77.6%) were imported from Central and West Africa. Malaria in VFR was mostly caused by P. falcipa-
rum infection after visiting Ghana (22%) or Nigeria (19%). Malaria in asylum seekers was mostly caused by Plasmodium 
vivax infection from the Horn of Africa. The large number of notifications in asylum seekers resulted from both an 
increase in number of asylum seekers and a striking increase of malaria incidence in this group. Incidence of malaria 
in asylum seekers from the Horn of Africa ranged between 0.02 and 0.3% in 2008–2013, but rose to 1.6% in 2014 and 
1.3% in 2015. In 2008–2012, incidence in tourists visiting Central and West Africa dropped markedly.
Conclusions: Imported malaria is on the rise again in the Netherlands, most notably since 2013. This is mostly due to 
immigration of asylum seekers from the Horn of Africa. The predominance of P. vivax infection among asylum seekers 
warrants vigilance in health workers when a migrant presents with fever, as relapses of this type of malaria can occur 
long after arrival in the Netherlands.
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Background
Malaria is caused by Plasmodium parasites and is trans-
mitted to humans through the bites of infected female 
mosquitoes. Most malaria cases and deaths occur in sub-
Saharan Africa. Other regions at risk are in Asia, Latin 
America and the Middle East. In 2015, 95 countries and 
territories had ongoing malaria transmission [1]. The 
World Health Organization (WHO) has declared the 
Netherlands malaria free since 1970. Nowadays malaria 
in the Netherlands occurs only as an imported disease 
in returning travellers or in visitors from endemic coun-
tries. Malaria is a mandatory notifiable disease in the 
Netherlands. Surveillance of imported malaria is used to 
monitor trends and as a feedback tool on the effective-
ness of pretravel health consultation and indications for 
malaria chemoprophylaxis. The national coordination 
centre for traveller’s health (LCR) is responsible for the 
national travel medicine guidelines for the Netherlands. 
An earlier study found a decreasing trend of incidence 
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of imported malaria in the Netherlands during the time-
period 2000–2007 [2]. The annual number of imported 
malaria infections fell from 535 in 2000 to 197 in 2007. 
Most recorded infections were caused by Plasmo-
dium falciparum (2131/2847; 75%), and most cases had 
recorded Africa as the most likely continent of infection 
(2068/2847; 82%). Almost half of all 2847 cases were 
travellers visiting friends and relatives (VFR) in Middle 
and West Africa. During this time period, malaria noti-
fications among VFR had decreased as well (from 210 in 
2000 to 77 in 2007) [2]. A decline in malaria incidence is 
seen globally; the WHO estimates a fall of 37% among 
populations at risk between 2000 and 2015 [1]. The risk 
of imported malaria, however, depends on several fac-
tors: malaria endemicity at the destination, the season 
of travel to the destination, the number of travellers to 
risk areas, the behavior of the traveller and adherence 
to personal protective measures like insect repellents, 
adequate use of chemoprophylaxis, and efforts for vec-
tor control around the accommodation. The aim of this 
study is to analyse trends in malaria notifications in the 
Netherlands, to assess whether the decline has persisted 
since 2007 and to identify risk groups. In recent years, 
the number of Dutch travellers to malaria endemic coun-
tries has increased [3] and since 2014 large numbers of 
asylum seekers from the Horn of Africa have arrived in 
the Netherlands. Although the incidence among asylum 
seekers was not studied separately in the previous study 
[2], in light of the recent increase in refugees seeking asy-
lum in the Netherlands, the additional aim is to quantify 
the incidence of imported malaria in asylum seekers.
Methods
Data sources
All malaria notifications received between 1 January 2008 
and 29 March 2016 were extracted from the Dutch elec-
tronic national surveillance system (‘Osiris’). A ‘date for 
statistics’ was defined as the day of onset of symptoms, 
or if this date was missing; the day of laboratory confir-
mation of malaria infection, or if this date was also miss-
ing; the day of notification. Because of possible delays in 
notification, all notifications received between 1 Janu-
ary 2008 and 29 March 2016 with a date for statistics in 
2008–2015 were included in the analysis.
Definitions
Whether a traveller was a VFR has been part of the noti-
fication questionnaire since July 2014. For notifications 
preceding this date or with missing data on reason for 
travel, a case was defined as VFR if the most likely coun-
try of infection matched the patient’s country of birth 
or the country of birth of either of the patient’s parents. 
Patients who were recorded as being asylum seekers or 
having visited the endemic country on business were 
excluded from the VFR definition, as were residents from 
endemic countries visiting the Netherlands.
For grouping countries of malaria infection, subcon-
tinents were categorized according to the composition 
of macro-geographical regions described by the United 
Nations Statistics Division [4], with the following modifi-
cations: Zambia was included in Central and West Africa, 
whereas China, Yemen and Madagascar were included in 
South and Central Asia (termed South Asia in reference 
2). Papua New Guinea was included in South East Asia. 
The United Nations Statistics Division describes the fol-
lowing regions: Africa (Eastern, Middle, Northern, South-
ern, Western), Americas (Northern, Caribbean, Central, 
South), Asia (Central, Eastern, Southern, South-Eastern, 
Western), Europe (Eastern, Northern, Southern, Western), 
Oceania (Australia and New Zealand, Melanesia, Microne-
sia, Polynesia). For grouping countries of origin of asylum 
seekers, an additional category was defined for the Horn 
of Africa, here defined as Eritrea, Ethiopia, Somalia, and 
Sudan. Sudan was included in the Horn of Africa category 
because this was often reported as the most likely country 
of infection for asylum seekers from Eritrea or Ethiopia.
Absolute number of imported malaria, 2008–2015
To evaluate trends, absolute numbers were used in spe-
cific risk groups (VFR or business or study travellers). 
During the period of 2008–2015, it was not possible to 
calculate incidence for these groups, because reliable 
data on travel statistics of the non-Dutch speaking popu-
lation, and business or study travellers were not available.
Incidence of imported malaria in tourists, 2008–2012
During the period of 2008–2012, incidence in tourists 
was calculated by using denominator data per country 
of travel from the Continuous Holiday Survey (NIPO), 
which were at the time of this study only available up to 
2012 [3]. This survey collects travel data from a random 
sample of the Dutch population four times a year. Partici-
pants complete a comprehensive questionnaire related 
to travel and holiday destinations over the telephone. 
The results are weighted to represent the general Dutch 
population. The questionnaire from the Continuous Hol-
iday Survey is in Dutch, so only Dutch speaking citizens 
can participate. Because it is known that a large group of 
mainly first generation immigrants in the Netherlands do 
not speak Dutch, these data were only used to calculate 
incidence in tourists to minimize bias.
Incidence of imported malaria in asylum seekers, 2008–
2015
During the period of 2008–2015, incidence of imported 
malaria in asylum seekers were calculated. Data on total 
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number of asylum seekers arriving in the Netherlands 
between 2008 and 2015 was kindly provided by the Cen-
tral Agency for the Reception of Asylum Seekers (COA). 
The country of origin of asylum seekers registered by 
COA was used in the analysis to determine denominators 
of asylum seekers per world region.
Analysis
Poisson regression was used to test trends in notifica-
tions. Coefficients were reported as incidence rate ratios, 
but for analyses which pertain numbers of notifications 
per year (without denominators), please note that ‘inci-
dence’ refers to the total number of national notifications 
(per risk group). In Poisson regression analyses where 
denominator data was available, this was added to the 
model as ‘exposure’. Analyses were performed in STATA 
13.0.
Results
Characteristics and absolute number of imported malaria, 
2008–2015
A total of 1941 malaria notifications with a date for sta-
tistics during the time-period 2008–2015 were received 
by the National Institute for Public Health and the Envi-
ronment. In 307/1941 (15.8%) cases the day of labora-
tory confirmation was used as date for statistics, as day 
of onset of symptoms was missing. In a further 12/1941 
(0.6%) cases, the day of laboratory confirmation was 
missing as well, and the day of notification was used for 
statistics. The median timespan that elapsed from onset 
of symptoms to notification was 10 days (range 0–324). 
Figure 1 shows the absolute number of imported malaria 
per year and also shows malaria notifications stratified 
by reason for travel (Fig.  1). Analysis for secular trend 
over the whole study period up to 2015 showed a small 
but significant increase in malaria notifications (IRR 
1.04 per year (95% CI 1.02–1.06, p  <  0.001) for all spe-
cies combined). However, time series analysis showed 
very slight downward trends up to 2013 in all malaria 
notifications combined (IRR per year 0.95, 95% CI 0.92–
0.98, p 0.002). Among tourist travellers, a slight decline 
in absolute numbers of imported malaria was seen over 
the whole study period up to 2015 (IRR per year 0.95, 
95% CI 0.91–0.99). Malaria cases among VFR increased 
markedly since 2013 (IRR 2.01 per year, 95% CI 1.63–
2.46, p  <  0.001). Among business or student travellers, 
yearly malaria notifications were stable (IRR 1.02, 95% CI 
0.98–1.07). Additional file 1 shows regions of infection of 
Dutch travellers stratified by travel purpose.
The majority of notified malaria cases (1337/1941; 
68.9%) was caused by P. falciparum infection, of which 
most (1254/1337; 93.8%) were imported from Africa; 
1037/1337 (77.6%) were imported from Central and West 
Africa. Most P. falciparum cases among VFR occurred 
after travel to Nigeria (19%) and Ghana (22%). There has 
been a significant increase in Plasmodium vivax notifi-
cations in recent years (from 16 in 2013 to 129 in 2015). 
The majority of the 372/1941 (19%) imported P. vivax 
infections in the time period 2008–2015 originated from 
the Horn of Africa (214/372; 57.5%), rather than Asia 
(107/372; 28.8%) or South America (12/372; 3.2%). A fur-
ther 129/1941 (7%) cases of Plasmodium ovale, 47/1941 
(2%) cases of Plasmodium malariae and one Plasmodium 
knowlesi infection were reported in 2008-2015. Mixed 
infections, most often infections by both P. falciparum 
and P. vivax, were reported in 13/1941 (0.7%) of cases. 
The causative species was unknown in 42/1941 (2%) 
malaria notifications. Table  1 shows the annual number 
of imported infection by Plasmodium species (Table 1).
Hospitalization occurred in 53.3% of all notified malaria 
cases and 7 deaths were notified. As all notified deaths 
occurred after P. falciparum infection, the case fatality 
rate for P. falciparum was 0.5%. While in 76/1941 (3.9%) 
of notifications the country of infection was unknown, 
also 8/1941 (0.4%) malaria cases were acquired in non-
endemic countries. Among them was one case of con-
genital vivax malaria in a baby born in the Netherlands 
to a mother who had fled from Eritrea, a case of quartan 
malaria acquired through blood transfusion and one clini-
cal trial participant who had been lost to trial follow-up 
after experimental malaria infection in another European 
Fig. 1 Malaria notifications 2008–2015 by reason for travel
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country. Five other cases of P. falciparum infection 
reported to be acquired in non-endemic countries may 
have been acquired in other countries than reported, may 
have been cases of ‘airport or luggage malaria’ or might 
have been relapses of misdiagnosed P. vivax or P. ovale 
infections [5]. A map showing the countries of origin of 
imported malaria infections is found in Additional file 2.
(Self‑reported) adherence to chemoprophylaxis in Dutch 
resident malaria patients
In 2008–2015, 28/1941 (1.4%) cases of P. falciparum malaria 
were notified in Dutch resident travellers despite self-
reported use of chemoprophylaxis according to the Dutch 
guidelines. Delayed onset of symptoms for P. vivax or P. 
ovale occurred in 53/1941 (2.7%) patients after using chem-
oprophylaxis according to the guidelines, which may be 
expected: Plasmodium species with persistent liver stages 
can establish infection despite adequate use of chemopro-
phylaxis [6]. One out of the 7 deceased patients took chem-
oprophylaxis (atovaquone/proguanil), but not according to 
the guidelines. The other 6 deceased patients did not take 
any prophylaxis. One of these was a Sudanese immigrant, 
all others were born in the Netherlands and above the age 
of 50. Five out of the six deceased Dutch travellers died of 
P. falciparum malaria after visiting The Gambia, which has 
been described before as a particular risk country [7, 8].
Whenever a notification of P. falciparum malaria 
despite chemoprophylaxis is received, the LCR investi-
gates whether there is concern for resistance to prophy-
lactic drugs in malaria parasites. In the majority of these 
cases, patients report illness with diarrhea or vomit-
ing during the prophylactic regimen, forgetting to take 
their drug adequately, or taking atovaquone/proguanil 
with a possibility of diminished bio-availability [9]. In 
cases where no plausible explanation for chemoprophy-
laxis failure was found, hospitals were asked for the thick 
smear for sequencing of the parasite. Unfortunately, none 
of these samples had been stored.
Incidence of imported malaria in tourists, 2008–2012
Figure  2 shows the incidence of malaria among tourist 
travellers in 2008–2012 (Fig.  2). A striking decrease in 
incidence of imported malaria originating from Central 
and West Africa was observed (IRR per year 0.72, 95% 
CI 0.64–0.81, p < 0.001). A large increase in travel to this 
region combined with a decrease in notifications under-
lies this decline. For 2013–2015 denominator data were 
not available, however in this period the yearly amount 
of notified cases after a visit to Central or West Africa has 
remained stable (20 cases in 2013 and 24 in both 2014 
and 2015).
Incidence of imported malaria in asylum seekers, 2008–
2015
High numbers of malaria cases related to asylum seek-
ers were notified in 2014 and 2015, this is shown in 
Fig.  1. Figure  3 shows the amount of asylum requests 
and malaria incidence among asylum seekers per world 
region of origin in 2008–2015. Of the 214/372 (57.5%) 
Table 1 Notified infections of malaria in the Netherlands, 2008–2015
Plasmodium species 2008 2009 2010 2011 2012 2013 2014 2015 Total
P. falciparum 178 187 185 175 142 128 163 179 1.337
P. vivax 20 28 32 33 30 16 84 129 372
P. ovale 14 14 19 18 15 13 17 19 129
P. malariae 4 1 8 12 7 6 5 4 47
Species unknown 4 1 2 4 3 3 16 9 42
Mixed infection 2 2 2 1 2 0 0 4 13
P. knowlesi 0 1 0 0 0 0 0 0 1
Total 222 234 248 243 199 166 285 344 1.941
Fig. 2 Incidence of malaria among tourists, by region of travel, 
2008–2012
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P. vivax cases originating from the Horn of Africa, 
199/214 (93.0%) cases were among asylum seekers. Inci-
dence of malaria in asylum seekers from the Horn of 
Africa ranged between 0.02 and 0.3% in 2008–2013 but 
rose to 1.6% in 2014 and 1.3% in 2015. Combined with 
the large number of asylum seekers from this region, this 
resulted in 234/259 (90.3%) of all malaria notifications 
in asylum seekers originating from the Horn of Africa in 
2014–2015. Of these, 185/234 (79.1%) were specified as 
P. vivax infections and 66/234 (28.2%) cases were chil-
dren <18 years. While asylum requests from Central and 
West Africa have remained stable, incidence of malaria 
in asylum seekers from Central and West Africa (which 
were mostly P. falciparum infections) has decreased dras-
tically (IRR per year 0.80, 95% CI 0.77–0.84, p < 0.001). 
The overall incidence of malaria in asylum seekers from 
endemic regions remained stable between 0.5 and 1.0%.
Discussion
Absolute number of imported malaria, 2008–2015
This report describes and analyses trends in the noti-
fications of imported malaria in the Netherlands dur-
ing the period 2008–2015. The decrease described for 
the time-period 2000–2007 continued up to 2013, after 
which the decline in imported malaria infections seems 
to have stagnated. In the time period 2000–2007 the 
majority of the imported P. vivax infections originated 
from Asia (192/388; 55%) [2]. This is in contrast to the 
time-period 2008–2015, in which the majority of the 
imported P. vivax infections originated from the Horn of 
Africa (214/372; 57.5%). This was mainly due to the large 
numbers of P. vivax infections imported from the Horn 
of Africa in 2014 and 2015. In recent years, increases 
in imported malaria have mainly occurred among VFR 
from West Africa and in asylum seekers from the Horn 
of Africa. The recent increase in malaria notifications in 
VFR travellers might largely be attributable to an increase 
in visits to Central and West Africa (in particular Nigeria 
and Ghana). This is in contrast to the previous study of 
van Rijckevorsel et al. [2] that found a decrease in malaria 
notifications among VFR. In the same study informa-
tion on the ethnic origin of the patients was available in 
2141/2847 (75%) of the records. Of these patients almost 
half (1042/2141; 49%) were persons of Middle and West 
African origin, mainly from Ghana and Nigeria, of which 
98 and 95% acquired the infection in the country of ori-
gin, respectively [2]. These findings are comparable to the 
results in this study.
(Self‑reported) adherence to chemoprophylaxis in Dutch 
resident malaria patients
Considering the number of malaria cases among Dutch 
travellers not using chemoprophylaxis (N  =  845), 
improvements can still be made in reaching travellers 
for pre-travel health advice. This has shown to be espe-
cially difficult with last-minute holiday bookers and VFR 
[10]. The majority of malaria cases reported not having 
used chemoprophylaxis according to national guidelines. 
Also, there is no presumption of resistance of P. falci-
parum to chemoprophylaxis, although the evidence is 
weak. Therefore, alternative options for protecting trav-
ellers against malaria in intermediate risk areas such as 
Fig. 3 Total number of asylum requests per world region of origin (a) and malaria incidence among asylum seekers per world region of origin (b) 
2008–2015
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stand-by treatment may improve uptake and adherence, 
both for tourists and VFR [11]. The main goal of pre-
scribing chemoprophylaxis is to prevent the traveller to 
succumb after a P. falciparum malaria infection. Recent 
studies have shown both pre-travel consultation and 
compliant use of chemoprophylaxis to be associated with 
lower severity of malaria [12, 13]. Of the seven deceased 
malaria cases reported in the Netherlands since 2008, 
none used chemoprophylaxis according to the guide-
lines. However, the true number of malaria deaths among 
Dutch travellers is not known, as patients may have died 
abroad or after their case was notified.
Incidence of imported malaria in tourists, 2008–2012
The most remarkable finding was the decreasing malaria 
incidence among tourists after travel to Central and West 
Africa (Figs. 1, 2). These observations may be the result of 
decreased prevalence of malaria in this region [14]. Ade-
quate protective measures might also have contributed to 
the decrease seen in tourists.
Incidence of imported malaria in asylum seekers, 2008–
2015
The large number of asylum seekers from the Horn of 
Africa arriving in 2014–2015 in the Netherlands resulted 
in high rates of imported malaria. The analysis in this 
study show this is not solely due to an increased num-
ber of asylum seekers, but also to an increased number 
of imported malaria cases among this risk group as the 
incidence in this group also increased. These cases were 
mostly caused by P. vivax infection. A recent increase 
in P. vivax malaria in Eritrean asylum seekers has also 
been observed in other European countries [15, 16]. The 
estimated incidence in asylum seekers from the Horn 
of Africa is in line with the incidence in Eritrean asy-
lum seekers in Sweden estimated by Sondén et al. (1.6% 
in 2014 in the Netherlands compared to 1.9% in the first 
months of 2014 in Sweden) [15]. The incidence of P. vivax 
in migrants from the Horn of Africa does not necessarily 
reflect the local epidemiology [17, 18], although a recent 
report from Ethiopia does support a predominance of P. 
vivax in this region [19]. Alternatively, migrants harbour-
ing a P. falciparum infection may either succumb to the 
complications of the infection or be successfully treated 
on the migratory route, whereas symptoms of P. vivax 
may present later upon arrival in the Netherlands due to 
dormancy or relapse. In addition, it has been suggested 
that refugee camps might form zones of enhanced P. 
vivax transmission [15]. Incidence of malaria in asylum 
seekers from Central and West Africa has shown a dras-
tic decline.
Limitations
This study has several limitations. The results are depend-
ent on the quality of the data provided in the notification 
questionnaire. It is uncertain to what extent risk groups 
such as asylum seekers or VFR are correctly classified. 
However, logical checks were used for this classification 
such as comparing country of birth to country of infec-
tion. Also, some misclassification may have occurred for 
the species of Plasmodium, as the microscopic determi-
nation of parasite species requires specific expertise and 
trained analysts. In addition, rapid antigen tests not dis-
tinguishing all species are increasingly used. Extensive 
clinical features were not included in the notification 
questionnaire. Clinical information other than hospitali-
zation or death was not available.
The calculation of malaria incidence in asylum seekers 
by using the asylum requests per year also has its limi-
tations: P. vivax malaria may present itself in a different 
year than the asylum request. Moreover, most people 
requesting asylum in a certain year will not have resided 
in the Netherlands for the entire year, therefore they may 
have had clinical malaria in months prior to entering the 
country.
The lack of denominator data for Dutch travellers 
divided by risk group (business, study and VFR travellers) 
precludes any conclusions about incidence of malaria in 
these groups. The increase in notifications of VFR cases 
to Central and West Africa may, therefore, be the result of 
an increase in total number of VFR visits, perhaps influ-
enced by the subsidence of the economic crisis. Possibly, 
the reduced local prevalence influenced risk perception 
and preventive behaviors among VFRs. However this 
hypothesis is not supported by a recent study from the 
United Kingdom showing that VFR travellers to Nigeria 
and Ghana have similar knowledge and risk perception 
as non-VFR travellers [20]. Alternatively, the addition 
of a specific VFR-question in the notification form since 
2014 may have increased the number of reported travel-
lers defined as VFR in the analysis. It is possible that for 
the period before the introduction of a VFR-specific risk 
category in the questionnaire, part of the VFR travellers 
were misclassified as asylum seekers (for cases where the 
risk group ‘immigrant’ was chosen). Such a misclassifica-
tion would partly mitigate the decrease in incidence in 
asylum seekers from Central and West Africa, as well as 
the increase in notifications among VFR. Furthermore, 
many countries have only regional malaria endemicity, 
or strong seasonality of transmission [21]. Therefore, it is 
often uncertain to what extent travellers are truly at risk 
of infection (and should be in the denominator to deter-
mine incidence).
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Conclusions
In conclusion, this study shows the decreasing trend in 
imported malaria in the Netherlands since 2000 has 
not continued. While the incidence among tourists has 
continued to decrease up to 2012, the amount of noti-
fied malaria cases in Dutch travellers (mainly VFR) has 
increased since 2013. Simultaneously, an increase in 
number of asylum seekers from the Horn of Africa as 
well as an increase in malaria incidence in this population 
resulted in high numbers of malaria cases among asylum 
seekers in the Netherlands since 2013. The predominance 
of P. vivax infection among asylum seekers warrants vigi-
lance in health workers when a migrant presents with 
fever, as relapses of this type of malaria can occur long 
after arrival in the Netherlands. The recent increase of 
malaria in VFR travellers shows that travel health clinics 
might still be inadequately reaching this specific group of 
travellers.
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